Engineers at the Massachusetts Institute of Technology (MIT) have developed a new type of customizable vaccine that could work against Ebola and other disease outbreaks, and could be deployed faste
A detailed understanding of serological immune responses to Ebola and Marburg virus infections will facilitate the development of effective diagnostic methods, therapeutics and vaccines. We examined antibodies from Ebola or Marburg survivors 1-14 years after recovery from disease, by using a microarray that displayed recombinant nucleoprotein (NP), viral protein 40 (VP40), envelope glycoprotein (GP), and inactivated whole virions from six species of filoviruses.
As the frequency and prevalence of zoonotic diseases increase worldwide, investigating how mammal host distributions determine patterns of human disease and predicting which regions are at greatest risk for future zoonotic disease emergence are two goals which both require better understanding of the current distributions of zoonotic hosts and pathogens. We review here the existing data about mammalian host species, comparing and contrasting these patterns against global maps of zoonotic hosts from all 27 orders of terrestrial mammals.
Researchers used the locations of 408 known Lassa fever outbreaks in West Africa between 1967-2012 and the changes in land use and crop yields, temperature and rainfall, behaviour and access to hea
A team of scientists from a Chinese university have developed a palm-sized instrument that can detect the Ebola virus more quickly than traditional way and track down the virus load in body fluid.
Digital payments to emergency workers saved time and more than $10m in costs during the Ebola epidemic in Sierra Leone, a United Nations-backed initiative has found.
